Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
Clinical trial NCT07375355 · RECRUITING
Trial details
- NCT number
- NCT07375355
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-12
- Primary completion
- 2028-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.